Alkylating agent interactions with the nuclear matrix.
The interrelationship of DNA to the nuclear matrix is integral to the organization of chromatin within the nucleus and to the DNA replication process. The influence of nitrosourea and nitrogen mustard interactions with the nuclear matrix were studied in log phase HeLa cells. Alkylation of the nuclear matrix by chlorozotocin (CLZ) or 1-(2-chloroethyl-3-cyclohexyl)-1-nitrosourea (CCNU) was 1.58 and 1.27 pmoles drug/micrograms protein, respectively, whereas carbamoylation by CCNU was 32.5 pmoles/micrograms. These constituted approximately 30% of the total (nuclear) drug modifications. The structural matricin fibrillar components of the matrix were alkylated and carbamoylated twice as much as the ribonuclear protein elements (RNP). However, when alkylations are measured per microgram of protein, the ratio of covalently bound drug to RNP:matricin was 1.2 for both CLZ and CCNU. The RNP:matricin carbamoylation ratio for CCNU was 0.9. The importance of DNA and matrix protein alkylations to the process of reassociation was studied. Under control conditions, in vitro, approximately 80% of the DNA was associated with the matrix at a protein:DNA ratio (micrograms for micrograms) of 50:1. Direct alkylation or carbamoylation of the matrix proteins did not affect these DNA-protein interactions. However, using in vitro alkylated DNA (1 alkylation/10(2) base pairs), there was a 60% reduction of the alkylated nucleic acid bound to the matrix at the same protein: DNA ratio. The reduced binding of DNA to matrix may be a function of interference with the DNA recognition sites by alkylation of specific bases. The interference of DNA-matrix association by DNA alkylation may contribute to the cytotoxic activity of these antineoplastic agents.
D000477:Alkylating Agents / Q000378:metabolism*; D002467:Cell Nucleus / Q000378:metabolism*; D002699:Chlorambucil / Q000494:pharmacology; D004247:DNA / Q000378:metabolism; D006367:HeLa Cells; D006801:Humans; D008130:Lomustine / Q000378:metabolism; D008770:Methylnitrosourea / Q000494:pharmacology; D011485:Protein Binding; D012261:Ribonucleoproteins / Q000378:metabolism; D013311:Streptozocin / Q000031:analogs & derivatives / Q000378:metabolism
D000477:Alkylating Agents; D012261:Ribonucleoproteins; D002699:Chlorambucil; C007028:chlorozotocin; D013311:Streptozocin; D008770:Methylnitrosourea; D008130:Lomustine; D004247:DNA